ChronoScale (CHRN)

NASDAQ:CHRN

CHRN

ChronoScale

RESEARCH TOOLSreports

Want to see CHRN full AI Analyst Report?

ChronoScale (CHRN) Price & Analysis

727 Followers

CHRN Stock Chart & Stats

$10.15

-$0.08(-9.64%)

At close: Jan 08 4:00 PM EST

$10.15

-$0.08(-9.64%)

Day’s Range― - ―

52-Week Range$2.73 - $20.34

Previous CloseN/A

VolumeN/A

Average Volume (3M)56.84K

Market Cap

$63.86M

Enterprise Value$28.59M

Total Cash (Recent Filing)$3.99M

Total Debt (Recent Filing)$4.32M

Price to Earnings (P/E)―

Beta1.53

Next Earnings

Aug 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-5.39

Shares Outstanding3,563,381

10 Day Avg. Volume46,910

30 Day Avg. Volume56,843

Financial Highlights & Ratios

PEG Ratio0.04

Price to Book (P/B)2.32

Price to Sales (P/S)1.64

P/FCF Ratio-1.75

Enterprise Value/Market Cap0.45

Enterprise Value/Revenue2.47

Enterprise Value/Gross Profit4.68

Enterprise Value/Ebitda-2.14

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.1

Revenue Forecast (FY)$19.38M

Bulls Say, Bears Say

Bulls Say

Financial ResultsReported revenues above consensus and a smaller-than-expected net loss per share point to improving financial performance and could boost investor confidence.

M&AProposed merger with Applied Digital Cloud could provide Ekso Bionics with additional capital and cloud resources to stabilize operations and accelerate product development.

Revenue MomentumSequential recovery in sales and improving gross margins suggest that earlier order delays were idiosyncratic and may support renewed revenue momentum.

Bears Say

Asset Sale RiskIntent to pursue sale or divestiture of the legacy MedTech business could reduce recurring medical revenues and introduce execution risk during any transaction process.

Corporate UncertaintyAnnounced strategic review and potential transactions create uncertainty about future direction and could weigh on the stock until strategic outcomes are clarified.

Strategy ChangeMove away from commercializing exoskeletons toward other priorities undermines clarity on the company's core market strategy and may concern shareholders focused on the original technology opportunity.

CHRN FAQ

What was ChronoScale’s price range in the past 12 months?

ChronoScale lowest stock price was $2.73 and its highest was $20.34 in the past 12 months.

What is ChronoScale’s market cap?

ChronoScale’s market cap is $63.86M.

When is ChronoScale’s upcoming earnings report date?

ChronoScale’s upcoming earnings report date is Aug 03, 2026 which is in 80 days.

How were ChronoScale’s earnings last quarter?

Currently, no data Available

Is ChronoScale overvalued?

According to Wall Street analysts ChronoScale’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does ChronoScale pay dividends?

ChronoScale does not currently pay dividends.

What is ChronoScale’s EPS estimate?

ChronoScale’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does ChronoScale have?

ChronoScale has 3,563,381 shares outstanding.

What happened to ChronoScale’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of ChronoScale?

Currently, no hedge funds are holding shares in CHRN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

ChronoScale Stock Smart Score

Outperform

Fundamentals

Return on Equity

-177.40%

Trailing 12-Months

Asset Growth

-27.98%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

ChronoScale

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.